Markets:

Overview

News

Currencies

International

Treasuries

Curaleaf Hldgs Inc (OP:CURLF)

2.340 +0.040 (+1.74%)

Streaming Delayed Price Updated: 1:57 PM EDT, Mar 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Curaleaf Hldgs Inc

< Previous 1 2 3 4 5 6 7 8 9

...

55 56 Next >

420 with CNW — Germany’s Growing Marijuana Industry Holds its Breath as Elections Loom

February 21, 2025

Via CannabisNewsWire

Topics Cannabis

420 with CNW — Pain Increases Odds of Cancer Patients Using Marijuana, Tobacco

February 18, 2025

Via Investor Brand Network

Topics Cannabis

420 with CNW — Pain Increases Odds of Cancer Patients Using Marijuana, Tobacco

February 18, 2025

Via CannabisNewsWire

Topics Cannabis

Cannabis Stock Valuations Reflect No Expectation Of Federal Reform: Study ↗

February 14, 2025

Viridian Capital's latest report shows cannabis stocks pricing in no rescheduling or 280E relief, leaving MSOs stuck in valuation limbo.

Via Benzinga

Topics Cannabis

420 with CNW — New Hampshire House Committee Discusses Measure to Legalize Recreational Cannabis

February 06, 2025

Via CannabisNewsWire

Topics Cannabis

Grön Launches New Edibles Flavors Across Curaleaf Dispensaries In Arizona ↗

December 03, 2024

Via Benzinga

420 with CNW — President Trump to Play Pivotal Role in Marijuana Policy Reform and Rescheduling

January 28, 2025

Via CannabisNewsWire

Topics Cannabis Government

420 with CNW — Data Shows After Ohio Legalized Marijuana, Fatal Car Crashes Have Dropped

January 15, 2025

Via CannabisNewsWire

Topics Cannabis

Cannabis Stock Movers For January 9, 2025 ↗

January 09, 2025

Via Benzinga

Topics Cannabis

Amplify To Liquidate Cannabis-Focused MJUS ETF As Regulatory Uncertainty Weighs On Sector ↗

January 08, 2025

Amplify ETFs plans to liquidate MJUS, a cannabis-related ETF, due to regulatory issues. Other cannabis ETFs also struggling with DEA's indecisiveness.

Via Benzinga

Topics Cannabis ETFs

DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags On ↗

January 08, 2025

DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review.

Via Benzinga

Topics Cannabis

Surgeon General's Alcohol Cancer Warning And Dry January: This Cannabis Company Has You Covered ↗

January 03, 2025

Just in time for Dry January, Curaleaf announced an expansion to the company's fast-acting Select Zero Proof Hemp THC Seltzers.

Via Benzinga

Topics Cannabis

420 with CNW — NORML Analysis Shows at Least 35,000 Studies Were Done on Cannabis in the Last 10 Years

January 03, 2025

Via CannabisNewsWire

Topics Cannabis

US Marijuana Research is Witnessing an Evolving Landscape

December 17, 2024

Via CannabisNewsWire

Topics Cannabis

The Price Is Right: This Weed Real Estate Stock Proves Conservative Strategies Bring Returns ↗

December 09, 2024

New Lake Capital Partners (OTC:NLCP), a real estate company focused on cannabis properties, offers an attractive investment with a 9.1% dividend yield, well above the return on 10-year government...

Via Benzinga

Topics Cannabis

420 with CNW — Marijuana Prices Gradually Reduce as Ohio’s Legal Market Grows

December 09, 2024

Via CannabisNewsWire

Topics Cannabis

EXCLUSIVE: Drug Expert Dr. Carl Hart Slams Cannabis Prohibition Amid Hemp-THC Surge ↗

December 09, 2024

Dr. Carl Hart discusses hemp THC, unregulated markets, and the need for federal cannabis legalization to reduce risks and protect consumers.

Via Benzinga

Topics Cannabis

Why Cannabis Sales Are Down In Massachusetts And New Mexico: The Numbers Behind The Dip ↗

December 08, 2024

Massachusetts' average revenue per dispensary dropped to $362k/month, down 8% year-over-year, in New Mexico sales went down 3% in November.

Via Benzinga

Topics Cannabis

Europe Says Thanks But We'll Do It Ourselves - Canada Leads In Raw Cannabis Exports, Not Oil ↗

December 06, 2024

While dried flower exports have flourished, the growth of Canada's cannabis extracts, including oils and vapes, has been more erratic.

Via Benzinga

Topics Cannabis

Illinois Cannabis Sales Back On Track In October Hitting $142.3M After Slight September Dip ↗

December 06, 2024

ollowing a drop in September cannabis sales numbers in Illinois, October figures totaled $142.3 million, a 4.2% increase sequentially, reported New Cannabis Ventures' Alan Brochstein. Cannabis sales...

Via Benzinga

Topics Cannabis

Ho-Ho-Holy Smokes! Record Weed Sales Drive Dispensaries To Stock Smart This Holiday Season ↗

December 05, 2024

Flower remained the top-selling form factor, accounting for 43% of total sales, followed by vape at 28%, and edibles.

Via Benzinga

Curaleaf Holdings: Is This Cannabis Company A Buy Or Hold? ↗

December 05, 2024

In this article, we analyze Curaleaf using technical indicators, focusing on key levels and potential mid-term strategies. Let's dive in.

Via Benzinga

Topics Cannabis

Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat? ↗

December 04, 2024

For investors, MariMed represents a fundamentally strong outlier, but industry-wide challenges remain a drag on stock performance.

Via Benzinga

Topics Cannabis

Diversify Around And Find Out: Can Vegas Superstore And Florida Sales Boost This Weed Penny Stock? ↗

December 03, 2024

Is this 40-cent cannabis stock undervalued? Zuanic & Associates dives into its growth potential and market prospects.

Via Benzinga

Topics Cannabis

Cannabis Cuts Opioid Prescriptions By 53%, Utah Study Suggests ↗

December 02, 2024

Discover how cannabis for pain management reduced opioid prescriptions by 53% in Utah, signaling new opportunities for medical markets.

Via Benzinga

Topics Cannabis

Cannabis Stock Gainers And Losers From November 29, 2024 ↗

November 29, 2024

Via Benzinga

Topics Cannabis

Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA? ↗

November 28, 2024

As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector.

Via Benzinga

Topics Cannabis

Flora Growth Taps Europe's CBD Boom With $500K Czech-Slovak Partnership Renewal ↗

November 27, 2024

Via Benzinga

Federal Policy Could Add $3 Billion To Cannabis Industry: On Track To Reach $55 Billion By 2030 ↗

November 26, 2024

According to LeafLink, over the next 2-3 years, 5,000 non-MSO retailers are projected to open in key states, increasing store counts by 70%.

Via Benzinga

Topics Cannabis

80% Leverage, 5.5x EBITDA: Is Cresco The High-Risk, High-Reward Play Investors Need? ↗

November 22, 2024

According to Z&A, its enterprise value (EV) to current sales ratio stands at 1.6x, lower than Curaleaf and Green Thumb, both at 2.2x.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

55 56 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.